Advanced Glycation End-Products in Blood Serum—Novel Ischemic Stroke Risk Factors? Implication for Diabetic Patients
New predictors of ischemic incidents are constantly sought since they raise the awareness of patients and their doctors of stroke occurrence. The goal was to verify whether Advanced Glycation End Products (AGEs), in particular AGE10, could be one of them. The AGE10 measurement was conducted using a...
Main Authors: | Aleksandra Kuzan, Anna Kozak-Sykała, Anna Fiedorowicz, Wojciech Kałas, Leon Strządała, Andrzej Gamian |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/13/2/443 |
Similar Items
-
Alcoholic Liver Disease Is Associated with Elevated Plasma Levels of Novel Advanced Glycation End-Products: A Preliminary Study
by: Kamil Litwinowicz, et al.
Published: (2022-12-01) -
The Genotoxic and Pro-Apoptotic Activities of Advanced Glycation End-Products (MAGE) Measured with Micronuclei Assay Are Inhibited by Their Low Molecular Mass Counterparts
by: Monika Czech, et al.
Published: (2021-05-01) -
Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications
by: Misganaw Asmamaw Mengstie, et al.
Published: (2022-09-01) -
The Role of Advanced Glycation End Products in Diabetic Vascular Complications
by: Sang Youl Rhee, et al.
Published: (2018-05-01) -
Insulin resistance and generation of advanced glycation end products
by: Alvaro Gudiño Gomezjurado, et al.
Published: (2013-04-01)